Phase II study of Yale modified FOLFIRINOX (mFOLFIRINOX) in locally advanced pancreatic cancer (LAPC)

Authors :: Jeremy S. Kortmansky
Howard S. Hochster
Bryan W. Chang
Stacey Stein
Jill Lacy
Charles Cha
Ronald R. Salem
Xiangyu Cong
Carol Hahn
Xiaopan Yao
Jia Li
Source :: Journal of Clinical Oncology. 33:e15274-e15274
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: e15274 Background: There is no standard management of LAPC. Although FOLFIRINOX is superior to gemcitabine in metastatic pancreatic cancer (MPC) (Conroy et al. N Engl J Med 2011;364:1817), this reg...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
FOLFIRINOX
Phases of clinical research
Gemcitabine
Surgery
Locally advanced pancreatic cancer
Internal medicine
Metastatic pancreatic cancer
medicine
business
medicine.drug

Full Text Access

Tools